SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-19-001669
Filing Date
2019-03-12
Accepted
2019-03-12 17:16:13
Documents
58
Period of Report
2018-03-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_031219.htm 8-K 13646
2 Q1 exh_991.htm EX-99.1 242700
9 GRAPHIC logo.jpg GRAPHIC 6080
  Complete submission text file 0001171843-19-001669.txt   2768670

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE FILE apto-20180331.xml EX-101.INS 513423
4 XBRL SCHEMA FILE apto-20180331.xsd EX-101.SCH 41269
5 XBRL CALCULATION FILE apto-20180331_cal.xml EX-101.CAL 24283
6 XBRL DEFINITION FILE apto-20180331_def.xml EX-101.DEF 265763
7 XBRL LABEL FILE apto-20180331_lab.xml EX-101.LAB 225873
8 XBRL PRESENTATION FILE apto-20180331_pre.xml EX-101.PRE 289875
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 19675932
SIC: 2836 Biological Products, (No Diagnostic Substances)